Jeannette Oosterwijk‐Wakka

Author

Also Known As

J C Oosterwijk-Wakka, J Oosterwijk-Wakka, J. C. Oosterwijk-Wakka, J. Oosterwijk-Wakka, J.C. Oosterwijk-Wakka, Jeannette C. Oosterwijk-Wakka, Jeannette C. Oosterwijk‐Wakka, Jeannette Oosterwijk-Wakka, Jeannette Oosterwijk‐Wakka

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Ludwig Cancer Research Saarland University

About

Jeannette Oosterwijk‐Wakka is an author at Radboud University Nijmegen specializing in medicine, urology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	510
2	Cell Biology	3	3	142
3	Engineering	1	1	67
4	Health Sciences	1	1	113
5	Biomedical Engineering	1	1	67

Jeannette Oosterwijk‐Wakka

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Immune responses to transgene and retroviral vector in patients treated with ex vivo–engineered T cells C. B. H. W. Lamers, Ralph A. Willemsen, Pascal van Elzakker, Blood	2010	365
Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250 Karin Grabmaier, Joost L. M. Vissers, Mirjam C.A. de Weijert, International Journal of Cancer	2000	177
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. Martijn G. Steffens, Otto C. Boerman, Jeannette Oosterwijk‐Wakka, Journal of Clinical Oncology	1997	156
Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma Johanna Sandlund, Egbert Oosterwijk, Kjell Grankvist, British Journal of Urology	2007	113
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250. Martijn G. Steffens, Otto C. Boerman, Pieter HM de Mulder, PubMed UrologyGenitourinary CancerMedicineProgressive Metastatic RccRenal Pathology	1999	113
Vaccination of Patients With Metastatic Renal Cell Carcinoma With Autologous Dendritic Cells Pulsed With Autologous Tumor Antigens in Combination With Interleukin-2: A Phase 1 Study Jeannette Oosterwijk‐Wakka, Dorien M. Tiemessen, Ivar Bleumer, Journal of Immunotherapy	2002	99
A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma Ivar Bleumer, Egbert Oosterwijk, Jeannette Oosterwijk‐Wakka, The Journal of Urology	2005	91
A rabbit model to tissue engineer the bladder Jody Nuininga, Hilco van Moerkerk, Alex Hanssen, Biomaterials Tissue EngineeringUrological ResearchUrologyEngineeringBiomechanics	2003	67
Expression of intermediate-sized filaments in developing and adult human kidney and in renal cell carcinoma. Egbert Oosterwijk, G N van Muijen, Jeannette Oosterwijk‐Wakka, Journal of Histochemistry & Cytochemistry Renal PathologyPathologyRenal VesiclesCytoskeletonIntermediate-sized Filaments	1990	67
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate. Otto C. Boerman, M. H. G. C. Kranenborg, Egbert Oosterwijk, PubMed In-didtpa DoseImmunologyImmunotherapeuticsImmunotherapyBivalent Chelate	1999	65

Page 1